home





























 

















 





















hrsa

participating institutions:
Johns Hopkins University AIDS Service, New York State DOH AIDS Institute, The CORE Center, Cook County Hospital



NEWS AND NEW DEVELOPMENTS



FDA and Bristol Myers Squibb Warn Against the Use of Zerit in Combination with Videx in HIV-Infected Pregnant Patients due to Potential Increased Risk of Lactic Acidosis [FDA talk paper T01-02, 1/5/01]: On January 5, 2001, BMS sent a letter alerting health care professionals concerning the increased risk of lactic acidosis and hepatic steatosis in pregnant women treated with d4T and ddI. The report is based on three cases of fatal lactic acidosis that occurred in pregnant women treated with this combination. The concern with use in pregnancy will now appear as a black box warning.
posted 1/26/2001





Copyright © 2001-2002. The National AIDS Education and Training Centers Program on behalf of its AETC National Resource Center. All rights reserved.

Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need, and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.